You have 9 free searches left this month | for more free features.

Direct acting antivirals

Showing 1 - 25 of 8,764

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HCV Trial in United States (Prophylaxis (P2W), Transmit and Treat (T&T))

Not yet recruiting
  • HCV
  • Prophylaxis (P2W)
  • Transmit and Treat (T&T)
  • New Orleans, Louisiana
  • +5 more
Dec 6, 2022

Treatment of Hepatitis c by Using Direct-acting Antiviral

Not yet recruiting
  • Hepatitis C
  • Direct Acting Antivirals
  • (no location specified)
May 9, 2022

The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry

Recruiting
  • Hepatitis C
  • Direct Acting Antivirals
  • Atlanta, Georgia
    The Taskforce for Global Health
May 6, 2022

Long Term Follow up of Chronic HCV Patients Receiving DAAS

Recruiting
  • Chronic Hepatitis c
    • Sohag, Egypt
      Sohag University Hospital
    Jun 29, 2022

    Heart Failure Trial in Los Angeles, Durham, Dallas (Epclusa)

    Recruiting
    • Heart Failure
    • Los Angeles, California
    • +2 more
    Jan 27, 2022

    Possible Differences in HCC Course Depending on DAA Treatment

    Recruiting
    • Carcinoma, Hepatocellular
    • +5 more
    • Direct Acting Antivirals
    • Warsaw, Mazowieckie, Poland
      Medical University of Warsaw
    May 11, 2022

    Against HCV Based on Direct-acting Antivirals in Real-life

    Completed
    • Chronic Hepatitis C Infection
    • Seville, Andalusia, Spain
      Valme University Hospital
    Jun 22, 2022

    DAA Uptake in Controlling HCV Epidemic and Modeling

    Recruiting
    • Hepatitis C
    • +2 more
      • San Diego, California
        Owen Clinic-University of California, San Diego
      Sep 1, 2021

      Hepatitis C Infection Trial in United States (MBL-HCV1, Telaprevir (Part 1), Sofosbuvir (Part 2))

      Terminated
      • Hepatitis C Infection
      • MBL-HCV1
      • +2 more
      • Boston, Massachusetts
      • +4 more
      Feb 4, 2021

      Kidney Failure, Hepatitis C Trial (Direct Acting Antivirals)

      Withdrawn
      • Kidney Failure
      • Hepatitis C
      • Direct Acting Antivirals
      • (no location specified)
      Aug 12, 2020

      Hepatitis C, Chronic Trial in Bilaspur (Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a)

      Completed
      • Hepatitis C, Chronic
      • Bilaspur, Chhattisgarh, India
        YR Gaitonde Centre for AIDS Education and Johns Hopkins Universi
      Apr 26, 2021

      Chronic Hepatitis c After Treatment With Direct Action

      Completed
      • Hepatitis C, Chronic
        • Sevilla, Spain
          Hospital Universitario Virgen macarena
        Nov 15, 2021

        s of Achieving SVR in Advanced Hepatic Fibrosis Related to

        Completed
        • HCC in Chronic HCV Patients With Advanced Liver Fibrosis
        • (no location specified)
        Mar 7, 2020

        HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],

        Completed
        • HCV Coinfection
        • +2 more
        • Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
        • Sofosbuvir/Velpatasvir (SOF/VEL)
        • Baltimore, Maryland
          Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
        Feb 10, 2022

        Direct Acting Antivirals for HCV Infection in Kidney Transplant

        Completed
        • Kidney Transplant; Complications
        • Hepatitis C, Chronic
          • Istanbul, Turkey
            Istanbul University
          Nov 8, 2019

          HCV RAS Testing in Public Health Programs

          Unknown status
          • Hepatitis C
          • +3 more
          • Direct Acting Antivirals
          • Chandigarh, India
          • +1 more
          Jan 22, 2020

          Hepatocellular Carcinoma, Hepatitis C, Tumor Recurrence Trial in Alexandria (Velpatasvir/Sofosbuvir)

          Active, not recruiting
          • Hepatocellular Carcinoma
          • +3 more
          • Alexandria, Egypt
            Alexandria University, Faculty of Medicine
          Jan 14, 2022

          Safety of Direct-acting Antivirals in Patients With Hepatitis C

          Completed
          • Hepatitis C, Chronic
          • Direct Acting Antivirals
          • (no location specified)
          Aug 5, 2019

          Hepatitis C Trial (Zinc Supplement)

          Not yet recruiting
          • Hepatitis C
          • Zinc Supplement
          • (no location specified)
          Jul 16, 2022

          Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney

          Recruiting
          • Diabetes Mellitus
          • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 27, 2023

          Chronic Hepatitis C Trial in Cairo (sofosbuvir plus daclatasvir, Sofosbuvir plus Ledipasvir)

          Unknown status
          • Chronic Hepatitis C
          • sofosbuvir plus daclatasvir
          • Sofosbuvir plus Ledipasvir
          • Cairo, Abbasseya, Egypt
            El Demerdash Hospital
          Dec 28, 2019

          Coronary Artery Disease, Bleeding, Direct Acting Anticoagulant Adverse Reaction Trial in Italy, Spain (Direct-acting oral

          Recruiting
          • Coronary Artery Disease
          • +2 more
          • Direct-acting oral anticoagulation
          • Rozzano, Milan, Italy
          • +3 more
          Mar 22, 2022

          Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

          Not yet recruiting
          • Liver Cancer
          • Houston, Texas
            M D Anderson Cancer Center
          Feb 9, 2023

          Direct-acting Antiviral Drugs in Treatment of Hepatitis C in

          Completed
          • Inflammatory Bowel Diseases
          • Hepatitis C Virus Infection
          • Assess the effectiveness and safety of DAAs in patients with IBD.
          • +2 more
          • Terrassa, Barcelona, Spain
            Hospital Universitari Mutua Terrassa
          Jul 8, 2022

          Frequency of Anxiety and Depression in Chronic Hepatitis C

          Unknown status
          • Chronic Hepatitis c
          • Direct Acting Antivirals
          • (no location specified)
          Jul 5, 2019